Purpose. The presence of alginate-overproducing (Alg + ) strains of Pseudomonas aeruginosa in cystic fibrosis patients is indicative of chronic infection. The Alg + phenotype is generally due to a mutation in the mucA gene, encoding an innermembrane protein that sequesters AlgT/U, the alginate-specific sigma factor. AlgT/U release from the anti-sigma factor MucA is orchestrated via a complex cascade called regulated intramembrane proteolysis. The goal of this study is to identify new players involved in the regulation of alginate production.
INTRODUCTION
Pseudomonas aeruginosa, a Gram-negative, ubiquitous bacterium is pathogenic to plants, animals and humans [1] [2] [3] [4] . The most severe P. aeruginosa infections in humans include endocarditis, malignant otitis externa, septicemia, endophthalmitis, eye keratitis, pneumonia and meningitis [5] . Annually, there are 51 000 P. aeruginosa infections of which 6700 are multidrug-resistant isolates causing 440 deaths in the USA [6] . The Centers for Disease Control and Prevention has ranked P. aeruginosa as a pathogen of serious threat level [6] .
P. aeruginosa is the leading cause of morbidity and mortality in patients with cystic fibrosis (CF) [7] . Colonization of the lungs of CF patients starts a few years after birth and remains for life [8, 9] . An early acute infection transitions to a chronic phase when isolated P. aeruginosa colonies exhibit a mucoid phenotype due to constitutive production of alginate (Alg + ) [8, 10, 11] . Although alginate-producing P. aeruginosa is primarily associated with CF individuals, occasionally it has been isolated from patients with bronchiectasis, urinary tract and middle-ear infections [2] . Mucoid P. aeruginosa strains have also been isolated from wastewater systems, and the guttural pouch of an equine with chronic mucopurulent nasal discharge [12, 13] .
The presence of alginate-producing strains in the lungs of CF patients is associated with poor prognosis [14, 15] . Alginate protects P. aeruginosa from phagocytosis, antibiotics, oxygen radicals and the host immune response [16] [17] [18] [19] [20] [21] [22] . The importance of alginate in the virulence of P. aeruginosa has also been demonstrated in mouse models [23] [24] [25] [26] [27] . Compared to wild-type P. aeruginosa, an alginate-overproducing strain causes aggressive polymorphonuclear (PMN) leukocyte infiltration (similar to human infection) and causes inefficient pulmonary clearance [26] . A protracted lung infection has the potential to spread to other organs such as the spleen as observed in the mouse model [26] . These properties suggest that alginate is an important virulence factor.
Exposing the bacteria to stress can induce alginate production. Mucoid conversion of P. aeruginosa in vitro can be triggered by growth in high osmolarity media, with limited nutrients (like nitrogen, phosphate and carbon), static culture in acetamide broth, continued culture in the presence of antibiotics, Pseudomonas Isolation Agar (PIA) supplemented with ammonium metavanadate, ethanol, dehydration and extended exposure to oxygen radicals such as hydrogen peroxide [18, 21, [28] [29] [30] [31] [32] . Alginate production can also be stimulated by anaerobiosis [24, 33, 34] . Although it is difficult to ascertain every factor involved, it appears that in CF patients, continuous exposure to antibiotics and PMN-derived hydrogen peroxide may be the major contributors of mucoid conversion in P. aeruginosa [21] .
Alginate production is tightly controlled by a myriad of regulatory factors. AlgR, AmrZ (previously called AlgZ), AlgB and AlgT/U regulate transcription of the algD operon [34] [35] [36] [37] [38] [39] [40] . AlgR and AlgB proteins are response regulators of different two-component systems, FimS-AlgR and KinB-AlgB, which are essential for high levels of alginate synthesis [40] [41] [42] [43] [44] [45] . However, the conserved phosphorylation domains of both AlgB and AlgR are not required for alginate production [34, 46, 47] . Phosphorylated AlgR is not needed for alginate production but plays a role in twitching motility [44] . Another protein that increases alginate production is AmrZ, a ribbon-helix-helix DNA-binding protein [35, 48] . The membrane-associated cyclic-dimeric-GMP synthesizing protein MucR is also required for the synthesis of alginate in P. aeruginosa [49] .
The master regulator of alginate synthesis is AlgT/U (s 22 ), which belongs to the family of the extracytoplasmic sigma factors and has high homology to SigE (s E ) found in Escherichia coli, Streptomyces coelicolor, Bacillus subtilis and Salmonella Typhimurium [34, [50] [51] [52] [53] [54] . Expression of algT/U is autoregulated, and AlgT/U, in turn, regulates expression of the algD, algB, algR, amrZ and mucE operons [35, [54] [55] [56] [57] . The algT/U gene is a part of the algT/U-mucA-mucBmucC-mucD operon that plays an essential role in converting nonmucoid P. aeruginosa into its mucoid phenotype [36, 55, 58] . MucA is an innermembrane protein, and its Nterminal domain in the cytoplasm sequesters AlgT/U and prevents its activity [59, 60] . Most mucoid CF isolates acquire mutations in mucA, and 84 % of these harbour a common allele known as mucA22 that has a deletion of one nucleotide in a stretch of five guanines located at position 426-430 of the ORF resulting in premature translation termination [23, 58, 61] . MucA truncation leads to the constitutive production of alginate. In addition, inactivation of mucB and mucD also leads to constitutive alginate production [36, [62] [63] [64] .
In the wild-type background, the release of AlgT/U requires the sequential degradation of MucA through a process known as regulated intramembrane proteolysis (RIP) (Fig. 1) , a process that is conserved from bacteria to humans [65, 66] . In P. aeruginosa, MucE accumulates in response to cell wall stress (Step 1, Fig. 1 ) then the site-1 RIP serineprotease AlgW is activated to clip the C-terminus of MucA between amino acids Ala 136 -Gly 137 in the periplasm (Step 2, Fig. 1 ) [67, 68] . Then, the site-2 zinc-metalloprotease MucP cleaves MucA within the innermembrane (Step 3, Fig. 1 ), but the exact cleavage site remains to be elucidated [66, 69] . The MucA fragment tethered to AlgT/U is further processed by a cytoplasmic protease protein complex ClpXP with the aid of the SspA protein, finally releasing the sigma factor AlgT/U [70, 71] . The MucA C-terminus that lies on the periplasmic side is presumed to bind MucB [59, 67] . It has been shown in vitro that the presence of MucB in the reaction mixture prevents the cleavage of MucA by the periplasmic protease AlgW [67] . MucD is a chaperone/protease that controls periplasmic protein quality and can trigger the degradation of MucA upon detection of abnormal protein accumulation [69, 72] . In the mucD mutants, an alternative RIP pathway appears to be activated in which MucP directly cleaves MucA without pre-cleavage by AlgW [68, 69] . The role of MucC is currently controversial: reportedly being a positive and a negative regulator of alginate production [73, 74] . AlgO is a serine periplasmic protease required for alginate production [75, 76] ; however, its precise role in the RIP cascade remains to be elucidated. AlgO, AlgW and MucD contain PDZ (PSD-95/Discs-large/ZO1) domains that are involved in protein-protein interaction [77] .
Besides mutations in biosynthetic and regulatory genes, alginate production in P. aeruginosa can be suppressed by various means that includes increasing the copy number of genes such as rpoD, prolonged growth in the presence of sulfate ions or without aeration [71, [78] [79] [80] . The reversion phenotype has been exploited to study the regulation and to find novel genes associated with alginate production [50, 76, 78] . The reversion from mucoid to nonmucoid, when grown without aeration, was partially mapped to mutations in algT/U and algO [55, 76] . In this study, the reversion phenomenon was further exploited to map novel genes using a genetically well-defined constitutively mucoid strain PDO300 with a mucA22 allele, derived from the prototypic nonmucoid PAO1 strain, to isolate nonmucoid variants that are termed suppressors of alginate production (sap) mutants [21, 76] . One of the previously uncharacterized sap mutants, sap27, was used in this study. Complementation and mutational analysis led to the identification of lptD (PA0595), encoding an outer-membrane protein (OMP) as being responsible for restoring the mucoid phenotype.
However, sap27 had no mutation in lptD, but did in algO. This study will explore the role of lipopolysaccharide transport protein D (LptD) and AlgO in alginate production.
METHODS
Bacterial strains, plasmids, media and primers The E. coli and P. aeruginosa strains and plasmids used are listed in Table 1 . E. coli was grown in Luria-Bertani (LB) medium supplemented with chloramphenicol (Cm, 10 µg ml À1 ), gentamicin (Gm, 15 µg ml
À1
) and kanamycin (Km, 25 µg ml À1 ) as required. P. aeruginosa was grown in LB or LB-PIA (at 1 : 1 LB agar and PIA) [59] . The LB-PIA media was used to select transconjugants. Tetracycline (Tc, 100 µg ml
) and gentamicin (Gm, 75 µg ml À1 ) were used for P. aeruginosa. Cultures were grown at 37 C unless otherwise stated. All primers (Table 2 ) used in the experiments were synthesized and supplied by Integrated DNA Technologies (Coralville, IA). [1] . Activated AlgW cleaves the periplasmic domain of MucA, releasing MucB along with a C-terminal fragment of MucA [2] . MucP induces site-2 cleavage [3] . SspA binds to the N-terminus of MucA [4] bringing the fragment to the ClpXP proteasome for degradation [5] . The free AlgT/U [6] binds to RNA polymerase (RNAP, a 2 ßß'w) to initiate transcription of genes in the alg regulon [7] leading to alginate production. The roles of LptD, AlgO, MucD and ClpP2 (has 40 % sequence identity with ClpP) in this pathway have not yet been established. MucD is hypothesized to inhibit the interaction of the MucE with AlgW. MucB is presumed to prevent the cleavage of MucA by AlgW. The proteins, AlgO, AlgW and MucD, contain PDZ (PSD-95/Discs-large/ZO1) domains that are involved in protein-protein interactions.
DNA manipulations
All molecular techniques were performed according to standard protocols [81] . DNA sequencing was performed at Genewiz (South Plainfield, NJ). All sequencing primers are listed in Table 2 .
Triparental mating
Plasmids and cosmids were conjugated into P. aeruginosa via triparental mating using mobilizer plasmids pRK2013 and pRK600 [82, 83] . Transconjugants were then selected for on LB-PIA (1 : 1) plates containing Tc (100 µg ml
À1
) or Gm (100 µg ml
).
Isolation of sap mutants
In total, 34 nonmucoid sap mutants were isolated in a previous study, and a subset of those were characterized earlier [76] . One of the uncharacterized mutants, sap27, is the subject of this study.
Complementation of sap27
En masse complementation was performed using the minimal tiling path (MTP) library (PAO1 library that contains 336 clones covering 93.7 % of the genome) obtained from Paul Phibbs, East Carolina University [84] . The 334 clones were previously pooled into four donor pools, each of which originated from the four microtitre plates (MTP1-MTP96, MTP97-MTP192, MTP193-MTP288 and MTP289-MTP334) [76] . To score for mucoidy, LB : PIA plates with and without glycerol were used to reduce false positives. After 1-2 days of growth at 37 C, colonies were restreaked to confirm the mucoid phenotype. The identity of the cosmid was confirmed as described previously [76] . ; colE1; a pSP157 derivative with lptE ORF from pSP160 subcloned downstream of lptD-surA creating an operon with lptD-surA-lptE downstream of P BAD pLptD-SurA-LptE; this study pSP162 Gm R ; colE1; a pMQ72 derivative with a 2.77 kb containing lptD fused to six histidine residues at C-terminus and cloned downstream of P BAD pLptD-His 6 ; this study Table 2 . Primers used in this study
Primer name
Sequences (5¢-3¢)* The ability of the cosmid pMO012217 to complement was further confirmed by using the original MTP strain -MTP36 (Table 1) .
Mutagenesis of pMO012217
The sap27 mutant strain with the pMO012217 cosmid has the mucoid phenotype. This phenotype in the transconjugants would be lost if the gene responsible for the complementation in the cosmid is disrupted by transposon (Tn) mutagenesis. To accomplish this, the pMO012217 cosmid was mutagenized in vitro using the EZ :: TN Tnaccording to the manufacturer's protocol. A 200 nanogram aliquot of pMO012217 was subjected to the EZ :: Tn5 <KAN-2> insertion reaction for 6 h (Epicenter Biotechniques, Madison, WI) followed by transformation into E. coli DH5a cells. The transformants were cultured in a plate containing Km (30 µg ml
À1
). More than 500 transformants were pooled as the donors for triparental mating with sap27. The transconjugants were screened for the nonmucoid phenotype. Then, the mutagenized cosmid was isolated from sap27, and the Tn junction was sequenced using the KAN-2 FP-1 primer (Table 2) to identify the disrupted ORF.
Alginate assay
In brief, cells from a single plate were harvested after growth in LB for 36 h and resuspended in 5 ml PBS (pH 7.4) and the OD600 was determined. Then, the cell suspension was centrifuged at 12 000 g for 30 min. The supernatant was collected, and the alginate was precipitated using 5 ml of 2 % (w/v) cetylpyridinium chloride. The mixture was centrifuged at 12 000 g for 10 min and the pellet was resuspended with 5 ml of 1 M NaCl and 5 ml of cold (À20 C)
isopropanol. The suspension was again centrifuged at 12 000 g for 10 min and the pellet was dried at 37 C for 30 min to evaporate any residual isopropanol. Finally, the pellet was resuspended in 5 ml of 0.9 % (w/v) NaCl. To determine the alginate concentration, a set of standards was made with sodium alginate (Sigma-Aldrich, St. Louis, MO). The amount of alginate was determined using a borate/carbazole method [85] . A 70-µl alginate sample was mixed with 600 µl of ice-cold borate solution then immediately placed on ice and was followed by the addition of 20 µl of 0.1 % carbazole, and mixed briefly. Then the mixture was heated for 30 min at 55 C, and the absorbance was measured at 530 nm. The absorbance was compared with standards to determine the alginate concentration which was expressed in mg per ml supernatant and normalized to the bacterial OD 600 =0.41 [68] . All the alginate assays were performed in triplicate.
Construction of plasmids containing the ORF lptDoperon, surA, pdxA and optP The ORFs, surA, pdxA and optP, were amplified from the genomic DNA of PAO1 using standard procedures [81] . The primer pairs SP_LptD_Operon_(F)-SP_LptD_O-peron_(R), SP_SurA_(F)-SP_SurA_(R), SP_PdxA_(F)-SP_PdxA_(R), and SP_OptP_(F)-SP_OptP_(R), (Table 2) were used to amplify the lptD-operon (5.01 kb), surA (1.29 kb), pdxA (0.98 kb) and optP (2.37 kb), respectively. The forward primers used contained a ribosome-binding site upstream of the start codon of the respective ORFs as well as 45-bp tails (shown in bold, Table 2 ) that target recombination downstream of the P BAD promoter on pMQ72 that has pRO1600 and colE1 origins of replication Table 2 . cont.
Primer name
Sequences (5¢-3¢)*
SP_LptD-HindII_6xHis (R) GCAaagcttTTAATGATGATGATGATGATGCATAGCTTGATCTTCACGTTGACG **The nucleotides in bold are the sequences that are used for homologous recombination and italicized nucleotides are used for the restriction digestion.
[86]. The respective reverse primers also have 44-bp tails (shown in bold, Table 2 ) that target recombination upstream of T1T2 transcriptional terminators present in the vector [86] . The vector pMQ72 was digested with restriction enzyme SmaI. Then the digested vector pMQ72 along with PCR product were co-transformed into overnight cultures of Saccharomyces cerevisiae [86] . The transformed cells were individually tested for the desired construct by colony PCR using the primer pair SP_Seq_pMQ72_(F)-SP_Seq_pMQ72_(R) for the presence of an insert [86, 87] . E. coli DH5a was then transformed with the recombinant pMQ72 plasmids containing their respective ORFs and screened for Gm resistance. The amplified ORFs from the recombinant plasmids were sequenced to ensure fidelity ( Table 2 ). The plasmids with P BAD driving the expression of lptD-operon, surA, pdxA and optP are pSP50, pSP155, pSP156 and pSP158, respectively (Table 1 ). These plasmids henceforth will be referred to as pLptD-operon, pSurA, pPdxA and pOptP, respectively.
Construction of plasmids containing the lptD, surA and lptE The ORFs, lptD (2.77 kb), lptD-surA (4.05 kb) and lptE (0.62 kb), were amplified from PAO1 genomic DNA using the primer pairs SP_LptD_(F)-SP_LptD_(R), SP_LptD-SurA_(F)-SP_LptD-SurA_(R) and SP_LptE_(F)-SP_LptE_ (R), respectively ( Table 2 ). The amplified product lptD and lptD-surA were digested with the enzymes EcoRI and XmaI then ligated downstream of P BAD in pMQ72 [86] that was cut with same restriction enzymes. Then, the resulting plasmids harbouring lptD and lptD-surA genes were named pSP51 and pSP157, respectively.
The PCR-amplified product of lptE was restriction digested by enzymes XmaI and Hindlll then ligated downstream of P BAD in pMQ72 digested with the same restriction enzymes. Then the lptE-harbouring plasmid was named pSP160. The lptE fragment of pSP160 was subcloned into plasmid pSP157 downstream of lptD-surA using restriction enzymes XmaI and HindIII to create pSP161. The plasmid pSP161 contains lptD-surA-lptE under the control of P BAD .
All constructs were sequenced to ensure fidelity using the appropriate primers shown in Table 2 . The constructs, pSP51, pSP157, pSP160 and pSP161, henceforth will be referred to as pLptD, pLptD-SurA, pLptE and pLptD-SurALptE, respectively.
His-tagging of LptD A 2.77-kb fragment with lptD was amplified from PAO1 genomic DNA using the primer pairs SP_LptD (F) and SP_LptD-6xHis (R) ( Table 2 ). The latter primer has six histidine codons added in-frame to the 3¢ end of the coding sequence of lptD. The amplified product with lptD-His 6 was then ligated downstream of P BAD in pMQ72 to construct pSP162 (pLptD-His 6 ). The cloned fragment was sequenced for fidelity. The plasmid pLptD-His 6 was introduced into the sap27 strain by standard electroporation [88] .
Western blotting
The sap27(pLptD-His 6 ) strain was grown to an OD 600 of 0.4 and induced with 2 % arabinose at 25 C for 2 h. Crude cellular extracts were prepared using Novagen BugBuster Protein Extraction Reagent as described by the manufacturer (EMD Chemicals, San Diego, CA, USA). The extract was then separated into a soluble and insoluble (membrane) fraction as per the manufacturer's instructions. The concentration of protein was determined by the bicinchoninic acid method [89] . Five micrograms of total protein were separated on a SDS-polyacrylamide gel, and the presence of LptD was visualized using anti-His 6 antibody (Thermo Scientific, Rockford, IL) using standard protocols. Sigma 70 was used as loading control and probed with conjugated Direct-Blot HRP and unconjugated purified anti-E. coli RNA sigma 70 antibodies (BioLegend, San Diego, CA, USA).
Construction of DalgO and DalgW strains
An in-frame deletion of algO was constructed using overlap extension PCR and homologous recombination as previously described [90] . The upstream and downstream flanking regions of algO using the primer pairs CC_Al-gO_P1_(F)-CC_AlgO_P1_(R) and CC_AlgO_P2_(F)-CC_AlgO_P2_(R), respectively were amplified and fused to construct the deletion ( Table 2 ). The PCR products were then ligated through another round of PCR, and cloned into the suicide vector pEXG2 [91] . The recombinant plasmid was introduced into PAO1 and PDO300, where the deletion replaced the wild-type algO on the chromosome via homologous recombination using a two-step process, involving screening by Gm sensitivity followed by sucrose resistance. PCR amplification of the region spanning the deletion, and sequencing confirmed the absence of algO. These deletion mutants were called PAODalgO and PDODalgO.
A gene-splicing method using the yeast system was used to generate a precise in-frame deletion of algW in P. aeruginosa [86] . Upstream (P1) and downstream (P2) flanking regions of algW were amplified from PAO1 genomic DNA by PCR using the primer pairs HK_AlgW_UF-HK_Alg-W_UR and HK_AlgW_DF-HK_AlgW_DR ( Table 2 ). The primers HK_AlgW_UF and HK_AlgW_DR had regions of homology to target recombination of P1 and P2 with pMQ30 vector [86] . The primer pairs also had complementary sequences at the 3¢ end to facilitate joining to create the P3 fragment, as well as stop codons (5¢-CTAGCTAGC-TAG-3¢) to prevent translational read through. The pMQ30 vector has double selection markers, URA3 for yeast and Gm R for E. coli [86] . Yeast cells were transformed with the P1, P2 and BamHl-digested linearized pMQ30 using standard protocols and colonies were selected on sucrose-uracil plates. The yeast colonies were checked for the presence of the P3 construct for algW deletions by amplifications using primer pairs HK_AlgW_UF-HK_AlgW_DR (Table 2) . Yeast DNA was isolated from the positive colonies as previously described [87] . E. coli DH5a was transformed with the recombinant pMQ30 plasmids containing P3 and screened for Gm resistance. The amplified P3 from the recombinant plasmids were sequenced to ensure fidelity. The constructs were then moved into the PAO1 strain using triparental mating and screened for single and double crossovers using counter selection with sucrose and Gm, as previously described [86, 87] . The presence of the gene deletion in all mutants was confirmed using standard molecular methods. The strain is henceforth referred to as PAODalgW. Using similar strategies, DalgW in mucoid PDO300 was constructed and named PDODalgW.
RNA isolation and cDNA synthesis RNA was isolated from P. aeruginosa wild-type PAO1 as described previously [92] . Briefly, 10 ml overnight cultures grown in LB broth at 37 C were washed with 0.85 % saline solution to remove spent media. Then the cells were subcultured in 15 ml by inoculating the culture in LB media at an OD 600 of 0.01 at 37 C and under 200 r.p.m. Subsequently, the cells were harvested when the culture reached an OD 600 of 0.5-0.6. The RNA was stabilized by addition of phenol-ethanol mixture as described previously [93] . Stabilized RNA was then isolated using RNeasy Mini Kit (Qiagen, Germantown, MD, USA) as per the manufacturer's protocol. Residual genomic DNA contamination was removed using RQ1 RNase-free DNase (Promega, Madison, WI, USA) and RNA was repurified using RNeasy Mini Kit (Qiagen, Germantown, MD, USA). The quality of purified RNA was assessed on a denaturing agarose gel (NorthernMax Gly, Ambion, Life Technologies, Carlsbad, CA) and quantified at OD 260 (BioTEK, Synergy HT, Winooski, VT, USA). cDNA was then synthesized by annealing NS5 random primers to total purified RNA, and subsequent extension was carried out using SuperScript III reverse transcriptase (Invitrogen, Life Technologies, Carlsbad, CA, USA).
RESULTS

Identification of the sap27 complementing cosmid
The sap27 mutant is a nonmucoid revertant isolated by growing mucoid PDO300 without aeration [76] . The mucoid phenotype in sap27 was restored via en masse complementation with the PAO1 minimum tiling path (MTP) genomic cosmid library [84] . The complementing cosmid was extracted and the junction where the P. aeruginosa genome fragment is integrated was sequenced to identify the genes contained in pMO012217 (PAO1 coordinates: 637 674 to 658 948; Fig. 2 ) [84] . To ensure that pMO012217 was the complementing cosmid, sap27 was re-conjugated with E. coli containing the original cosmid clone from the MTP library (MTP36) (Fig. 3a) . As negative controls, PAO1 and sap27 were transformed with vector pLAFR3. As expected, PAO1 with the vector remained nonmucoid. The positive controls, the Alg + parent PDO300 with the cosmid and plasmid vectors, remained mucoid when transformed individually. The cosmid pMO012217 restored the mucoid phenotype in sap27 (Fig. 3a) . The pMO012217 cosmid contained 18 ORFs (Fig. 2) and did not harbour any known alginate genes indicating that a novel ORF was involved in the restoration of alginate production.
Mapping the gene in the complementing cosmid pMO012217 using Tnmutagenesis To date, none of the ORFs present in the cosmid were known regulators. To map the ORF responsible for the complementation, the cosmid pMO012217 was Tn mutagenized in vitro. The Tn mutant library was introduced into sap27 and screened for the loss of the mucoid phenotype in the transconjugants. A single clone was isolated. Sequencing of the Tn junction in the construct that failed to restore the mucoid phenotype using the cos-1 ( Table 2 ) primer revealed the insertion to be at the 3¢ end of lptD (PA0595) at position 653 902 of P. aeruginosa PAO1 genome (Fig. 2) . This insertion disrupts the alanine codon at the position 876 of LptD, truncating the protein (Fig. 2) .
Analysis of the lptD locus
Analysis of the locus suggests that lptD might be part of a three-gene operon [94] . Thus, the Tn insertion could have a polar effect on the downstream genes, namely surA and pdxA. In E. coli, it has been shown that SurA is an essential protein for survival in starvation and a major chaperone protein for all OMPs [95] [96] [97] [98] . In E. coli, PdxA is an NADdependent dehydrogenase, and is involved in the vitamin B 6 biosynthetic pathway [99, 100] . To verify if lptD-surA-pdxA forms an operon in P. aeruginosa, total RNA was isolated from PAO1 in late log-phase, and nonspecific primers were used to synthesize cDNA for reverse transcription PCR. The presence of a PCR amplicon with the primer pairs spanning the ORFs lptD-surA and surA-pdxA would suggest that these genes form an operon. The expected PCR products of sizes 1000 bp (lanes 2, 3 and 5) and 900 bp (lanes 8, 9 and 11) for lptD-surA and surA-pdxA, respectively, were observed (Fig. 4) . As expected, there was no product in negative controls when amplification was done without the DNA polymerase (lanes 7 and 13); or using RNA prepared after DNAse I treatment (lanes 4 and 10) or without reverse transcriptase (lanes 6 and 12). The presence of expected PCR products in the cDNA (lanes 5 and 11) confirms the existence of mRNA spanning the junctions. These data suggest lptD, surA and pdxA form an operon.
Since the Tn is inserted at the 3¢ end of the first gene, lptD, at 653 902 in the three-gene operon, it is possible that all three genes may be involved in alginate production (Fig. 2) . Thus, the three ORFs in the lptD-operon alone or combination might be responsible for restoring the mucoid phenotype in sap27. To determine the ORF responsible, lptD, surA and pdxA were individually cloned downstream of the P BAD promoter and the plasmids were named pLptD, pSurA and pPdxA, respectively (Table 1 ). In addition, the entire operon was also subcloned into the same vector. All the constructs were introduced into sap27 and PDO300. The vector (pMQ72) was also introduced into sap27 and PDO300 as negative controls. The plasmid harbouring mucE (pMucE) that is known to induce alginate production was introduced into sap27 and PAO1 as a positive control (Fig. 3c) [68] . After 36 h, the mucoid phenotype in sap27 was restored by the pLptD-operon and pLptD in the presence of arabinose (2 %) (Fig. 3b) but not by pSurA and pPdxA (Fig. 3d) . As expected, the amount of alginate produced by sap27 in the presence of lptD and lptD-operon was Fig. 3 . Identification of genes responsible for restoring the mucoid phenotype. (a) The cosmid pMO012217 introduced into sap27 restored the mucoid phenotype. PAO1 and PDO300 were used as negative and positive controls, respectively. The plasmid pLAFR3 was used as a control vector. (b) The plasmids, pLptD and pLptD-operon, which harbour lptD and lptD-surA-pdxA were separately introduced into sap27 restoring the mucoid phenotype. (c) The plasmids, pMucE and pLptD, were introduced into PAO1 and sap27, inducing a mucoid phenotype. (d) The plasmids, pSurA, pPdxA and pAlgO, were introduced into sap27. The mucoid phenotype was restored only when sap27(pAlgO) was induced with arabinose. Strains were plated on LB containing 2 % arabinose (Ara), where indicated, and incubated at 37 C for 36 h.
comparable to PDO300 (Fig. 5) . These findings suggest that lptD alone is sufficient to restore the mucoid phenotype in sap27.
Co-expression of lptD, surA and lptE in sap27 The 20-kDa LptE protein is essential for proper folding of LptD in the outer membrane [101] [102] [103] . In addition, LptD folding also requires the chaperone protein SurA [95] . One could argue that alginate production in sap27 is due to stress induced by the accumulation of misfolded LptD as a result of increased expression of lptD alone without surA and/or lptE. To rule out the potential for LptD misfolding, plasmids with lptD-surA (pLptD-SurA) and lptD-surA-lptE (pLptDSurA-LptE) under the control of P BAD were constructed (Table 1 ). These constructs were introduced individually into sap27 and the genes were induced with arabinose. Alginate production was restored in sap27 in the presence of both of the plasmids individually (Fig. 5 ). This suggests that the mucoid conversion of sap27 upon lptD overexpression is not due to misfolding of LptD, instead, it is the function of increasing the copy number of lptD. The latter would then imply that the concentration of LptD will be higher in sap27 if the expression of lptD is induced. We confirmed this by His-tagging LptD and Western-blotting using antiHis 6 antibody (Fig. 6 ). In addition, we also demonstrate that the LptD is only found in the insoluble fraction suggesting membrane localization (Fig. 6 ).
Expression of optP encoding a large OMP in sap27
To determine if the mucoid restoration of sap27 is exclusive to lptD, optP (PA0192) was expressed under the P BAD promoter in sap27. The protein OptP was chosen as it is predicted to be a large OMP (790 aa) comparable in size to the 924-aa LptD [94] . Overexpression of optP did not turn the sap27 strain into the mucoid phenotype and consequently no alginate was detected (Fig. 5) , suggesting that it is not a general function of large OMPs. This suggests that LptD might have potentially a specific role for alginate production in sap27.
Mapping of the mutation in sap27
The above finding suggested that sap27 harbours a mutation in lptD. To rule out any promoter mutation that may influence lptD expression, the entire operon including the promoter region was sequenced and no mutation was found. This suggested that the increased expression of lptD must be bypassing some other mutation. Our preliminary studies showed that the mucoid phenotype in sap22 with a mutation in algO (PA3257) can be rescued by another cosmid [75, 76] . This led to our hypothesis that sap27 may harbour a mutation in algO (PA3257). The introduction of a plasmid carrying algO (pAlgO) into sap27 rescued the mucoid phenotype (Figs 3d and 5) . Ideally, the cosmid containing algO should have complemented sap27 in the original en masse screening. However, it was missed in-part due to the subjective nature of the procedure. Fig. 4 . Verification of lptD as part of a three-gene operon. The PCR amplification of the junctions between the genes, lptD-surA and surA-pdxA were done using the primer pairs described in Table 2 . Amplified products were run on a 1 % agarose gel. Lane 1, 1 Kb ladder (M) as a marker; lanes 2-7 and lanes 8-13 are PCR products of the junction between lptD-surA and surA-pdxA, respectively. Lanes 2 and 8, PCR products from the genomic DNA (G) used as positive controls; lanes 3 and 9, PCR products from the RNA before DNAse treatment and cDNA synthesis (bT); lanes 5 and 11, PCR products from the cDNA (cD). The following were negative controls: lanes 4 and 10, RNA after the DNase treatment (aT); lanes 6 and 12, PCR amplification without the reverse transcriptase (-RT); and lanes 7 and 13, PCR amplification in the absence of DNA polymerase (-P).
The sequence analysis of algO encoding a 709 amino acid long protein in sap27 genome revealed an insertion of a single nucleotide, thymine (T) at position 3,643,250 (Fig. 7) . This insertion results in a frame-shift mutation leading to premature termination of algO at codon 320 (Fig. 7) , which is converted from glutamic acid to UGA, an opal stop codon. The truncated protein has identity to AlgO at the first 106 amino acids of the N-terminus and the remaining 213 amino acids share no similarity to any other P. aeruginosa proteins. In fact, the same mutation was identified in sap22 [75, 76] . However, the codon number was stated differently as the start codon for algO is off by 11 codons that were recently corrected on pseudomonas.com [94] .
To ensure the phenotype seen in sap27 is not strain-specific, and that it can be reproduced in sap22, the plasmid pLptD was introduced in the latter rescuing the mucoid phenotype (Fig. 3c) . To further confirm that lptD in trans can overcome the algO mutation, a clean in-frame deletion of algO was constructed in PAO1 and PDO300 and the strains were named PAODalgO (Alg À ) and PDODalgO (Alg À ), respectively. The plasmid pLptD-SurA-LptE was introduced in these strains and induced with arabinose.
The increase in lptD copy number (expected to be between one and seven copies [104] ) ledto higher protein levels in PAO1 and PAODalgO resulting in the strains turning mucoid with significant production of alginate (Figs 3c, 5 and 6). Thus, the LptD-dependent alginate production does not require algO. The induction of lptD in PDODalgO (Alg À ) failed to rescue the alginate phenotype (Fig. 5) . However, the alginate phenotype can be rescued by lptD in the sap27 mutant strain (Fig. 5 ). Both these strains express truncated MucA (MucA22). The difference between PDODalgO and sap27 (PDOalgO107) is that one has no AlgO whereas the latter expresses a truncated AlgO. This suggests that LptD-dependent alginate production in sap27 requires the truncated AlgO. One cannot rule out the possibility that the 213 amino acid tail in the AlgO107 is contributing to the observed phenotype.
Increased expression of lptD-surA-lptE in the DalgW mutant of PAO1 and PDO300 To determine if LptD-dependent induction of alginate production has a role in the RIP cascade, attempts were made to construct deletion mutants of algW and mucP. Repeated efforts to make mucP deletion mutants failed. However, Fig. 5 . Alginate levels in the presence of increased expression of lptD. Plasmids containing the lptD-operon, lptD, lptD-surA, lptD-surAlptE, optP and algO were introduced into the strains as indicated -sap22, sap27, PDO300 and those with a precise in-frame deletions of algO (PAODalgO and PDODalgO) and algW (PAODalgW and PDODalgW). Cells were grown for 36 h on LB plates supplemented with gentamycin (100 µg ml À1 ) for selection, and in the absence or presence of 2 % arabinose as an inducer (indicated by + and -). The alginate levels were quantified and normalized to an OD 600 =0.41 as described in Methods. Strains with vectors were used as the negative controls and the mucoid PDO300 as the positive control. The level of significance (P-value) using Student's t-test is less than 0.05 for each set of experiments. The experiments were done in triplicate.
PAO1 and PDO300 derivatives with clean in-frame algW deletions were constructed, and are referred to as PAODalgW and PDODalgW, respectively. As expected, the loss of algW resulted in the loss of alginate production in PDO300 (Fig. 5) . Multiple efforts to complement PDODalgW with algW also failed. The plasmids pLptD and the pLptD-SurA-LptE were introduced into PAODalgW and PDODalgW. The mucoid phenotype of PDODalgW was rescued by increasing the copy number of lptD (Fig. 5) . Inducing the expression of lptD in PAODalgW did not result in alginate production (Fig. 5 ). This suggests that the LptDdependent alginate production in PAO1 requires AlgW. Thus, in a mucA22 background, LptD can bypass AlgW.
DISCUSSION
The emergence of alginate-producing strains of P. aeruginosa in patients with CF is an indication of chronic infection that signals a deterioration of lung function and ultimately pulmonary failure. The importance of alginate in CF patients was corroborated in the early 1970s. However, the genetic determinant responsible for the conversion was mapped to a single locus in the 1980s, and the genes responsible were identified in the 1990s. Almost 35 years later, with the identification of over 30 alginate genes, a solution to prevent mucoid conversion continues to elude us. This study was undertaken to identify novel genes by mapping second site-suppressor mutations of alginate production. The gain-of-phenotype in a nonmucoid sap27 was mapped to lptD (PA0595) encoding an OMP. To date, all genes involved in the regulation of alginate production encode for products that reside in the periplasm, the innermembrane and the cytoplasm. This report demonstrates the potential role for a P. aeruginosa OMP, LptD (PA0595), in alginate production.
LptD transports lipopolysaccharide (LPS) to the outer leaflet of the outer membrane and is an essential OMP in E. coli and P. aeruginosa but not in Neisseria meningitidis [105] [106] [107] . In E. coli, LptD is a member of the s E regulon with multiple designations: LptD, OstA and Imp owing to its different roles [107] [108] [109] [110] [111] . The LptD designation comes from LPS transport protein because of its involvement in outermembrane biogenesis [107, 112] , OstA comes from organic solvent tolerance A because of its importance in the growth of E. coli K12 in xylene and n-hexane [109, 110] ; and finally, Imp for increased membrane permeability that contributes Fig. 6 . Detection of LptD protein by Western blotting. His-tagged LptD was introduced into sap27 as described in Methods. Whole cell fractions were extracted from cells that were uninduced (-) or induced (+) with 2 % arabinose for 3 h at 25˚C. The induced whole cell extract was further separated into soluble and membrane or insoluble fractions. The presence of LptD was shown using anti-His 6 antibody. Sigma 70was used as the loading controls. The whole cell and membrane fractions were probed with unconjugated purified anti-E. coli RNA sigma 70 antibodies. The soluble fraction was probed with conjugated Direct-Blot HRP anti-E. coli RNA sigma 70 antibody, thus the ladder that was run parallel was superimposed in this image. Fig. 7 . Mapping the algO mutation in sap27. Codon numbers of the wild-type algO are shown on top. Sequencing of algO from sap27 using the primers CC_AlgO_Seq_1-11 (Table 2) revealed an insertion of a nucleotide thymidine (T) (shown in red) causing a frame shift at codon 107 leading to premature translational termination of AlgO at codon 320 resulting in a truncated protein. The amino acid sequence from codon 107 to 319 shares no similarity to any other P. aeruginosa proteins.
to the resistance to antibiotics, detergents and dyes [111, 113] . P. aeruginosa LptD is also involved in LPS transport, controls membrane permeability and confers resistance to antibiotics such as rifampin, ciprofloxacin, tetracycline, novobiocin, azithromycin and imipenem [105, 114] . Similar to E. coli, P. aeruginosa LptD is involved in LPS palmitoylation [114] [115] [116] . It is not uncommon to find proteins with multiple roles in bacterial physiology, for example AlgC is involved in LPS, Pel, Psl, alginate and rhamnolipid production [117] [118] [119] .
OMP LptD regulates alginate production One can argue that increasing expression will lead to misfolding of LptD that may cause alginate production in sap27, since it requires LptE and the SurA chaperon [101, 120] . However, the co-expression of lptD with surA and lptE continued to restore the mucoid phenotype of sap27 ruling out misfolding of LptD (Fig. 5 ). Further expression of optP encoding an OMP of comparable size in sap27 did not result in rescuing the mucoid phenotype (Fig. 5) . These results certainly argue that LptD, an OMP, may have a specific role in the regulation of alginate production.
LptD bypasses AlgO107
It is interesting that the sap27 strain did not have any mutations in the lptD locus, but in algO. A role for LptD in alginate production is further augmented by its ability to rescue the loss of the mucoid phenotype in sap22 that was previously identified with the same algO mutation (Fig. 5) . In a previous publication, the allele was named algO96 [76] . However, with correction of the ATG start codon location upstream, we renamed the allele algO107. Increasing the expression of lptD bypassed algO107 but failed to rescue the alginate phenotype when algO was completely deleted in PDO300. This suggests that the presence of truncated AlgO contributes to the observed phenotype. This phenotype is independent of the proteolytic activity of AlgO as the truncated protein (AlgO107) is missing that catalytic triad Ser490, Asp501 and Lys515. It is not possible to rule out that the 213 amino acid tail in the AlgO107 is contributing to the observed phenotype without further experimentation. In addition, PDO300 expresses a truncated MucA due to a loss of a guanine at nucleotide position 430 of mucA that results in premature termination [21] . Previously, it was argued that MucA22 is the substrate for AlgO, a putative serine protease [75] . However, no concrete evidence has surfaced to support this argument.
LptD influences members of the RIP cascade
To determine if LptD played a role in the RIP cascade, algW was deleted in PDO300 and PAO1. The loss of alginate Fig. 8 . Model for mucoid conversion due to increased expression of lptD in the mucA+ (PAO1) and mucA22 (PDO300) backgrounds. We propose that (a) in PAO1, increased expression of lptD displaces MucB and induces AlgW to cleave MucA resulting in proteolysis of MucA as described previously in Fig. 1 . There might not be any role for AlgO in PAO1 under the tested conditions; (b) in the mucA22 background, MucB cannot bind to MucA, thus the cleavage site of MucA22 is exposed. The overexpression of lptD might activate the truncated AlgO leading to MucA22 proteolysis via an unknown mechanism. production in PDODalgW was rescued by increasing lptD expression (Fig. 5) . This observation suggests that the release of AlgT/U by MucA22 (Fig. 1) does not require site-1 cleavage by AlgW, despite the fact that the major AlgW cleavage site on MucA (A 136 and G 137 ) is still present in MucA22 [69] . However, in the wild-type P. aeruginosa PAO1, mucoid conversion by overexpression of lptD requires AlgW. This finding argues that LptD directly or indirectly influences the members of the RIP cascade.
Two pathways for MucA proteolysis As previously shown, our results also suggest a difference in the regulation of alginate production in the wild-type versus isolates with the mucA22 allele [68] . In the wild-type background, alginate production is very tightly controlled since MucA is intact and protected by MucB against proteolytic cleavage [67] . We propose that, upon increased expression of lptD, AlgW is activated to initiate MucA cleavage followed by MucP to release AlgT/U for alginate synthesis (Fig. 8a ). In the mucoid P. aeruginosa isolates with the mucA22 allele, AlgO seems to be playing an important role by activating cleavage of the truncated MucA22 (Fig. 8b) either directly or indirectly by means of some unknown protein. Mechanistically, the specific role of LptD in the activation of AlgW or AlgO is not clear at the moment. The regulation of alginate production seems to be particular to the strain backgrounds and requires further investigation.
The X-ray crystal structure of E. coli LptD reveals the presence of a C-terminal b-barrel domain and N-terminal periplasmic domain with a jelly-roll-like structure [121, 122] . Bioinformatic analysis shows LptD of P. aeruginosa is structurally similar to that of E. coli [105] . It is not known whether the N-terminal domain of LtpD could interact with other periplasmic proteins to induce alginate production. Moreover, it is possible that the N-terminal domain of LptD or LPS might displace MucB, leaving MucA vulnerable to proteolysis (Fig. 8a) , as seen in the E. coli counterpart [123] [124] [125] . To understand the mechanistic detail, standard protein-protein interaction studies (pull-down, cross-linking, competition assays) can be performed to explore if there is any direct interaction between LptD and MucB and/ or MucA.
Implication
To date, P. aeruginosa LptD has not been associated with alginate production. P. aeruginosa LptD is a target of peptidomimetic antibiotics based on the antimicrobial peptide protegrin I that appears to be species-specific [105, 126] . It is also shown that depletion of LptD results in antibiotic susceptibility in P. aeruginosa and Acinetobacter baumannii [114, 127] . Furthermore, LptD is a subject of study for a candidate vaccine in Gram-negative bacteria such as N. gonorrhoeae and Vibrio parahaemolyticus [128, 129] . Multidimensional protein identification technology showed that in P. aeruginosa 63 proteins including LptD are exposed to the extracellular environment [126, 130] . Thus, it would be interesting to determine if the peptidomimetic antibiotics, as well as a vaccine against LptD, can prevent alginate production in P. aeruginosa.
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